TipRanks
Tiziana Life Sciences Plc (DE:0RP)
FRANKFURT:0RP
Germany Market

Tiziana Life Sciences (0RP) Stock News & Sentiment

0 Followers
Tiziana Life Sciences Seeks FDA Orphan Status for Intranasal Foralumab in Multiple System Atrophy
Premium
Company Announcements
Tiziana Life Sciences Seeks FDA Orphan Status for Intranasal Foralumab in Multiple System Atrophy
6d ago
Tiziana Life Sciences Doses First Participants in Phase 2a ALS BANYAN Trial of Intranasal Foralumab
Premium
Company Announcements
Tiziana Life Sciences Doses First Participants in Phase 2a ALS BANYAN Trial of Intranasal Foralumab
8d ago
Buy Rating Reiterated on Foralumab Data Catalysts, $7 Price Target Maintained
Premium
Ratings
Buy Rating Reiterated on Foralumab Data Catalysts, $7 Price Target Maintained
14d ago
Tiziana Life Sciences Completes Last Patient Visit in Phase 2a INFORM-MS Trial
Premium
Company Announcements
Tiziana Life Sciences Completes Last Patient Visit in Phase 2a INFORM-MS Trial
15d ago
Tiziana Life Sciences Signs Saudi Collaboration MOU for New Multiple Sclerosis Trial
Premium
Company Announcements
Tiziana Life Sciences Signs Saudi Collaboration MOU for New Multiple Sclerosis Trial
19d ago
Tiziana Life Sciences Showcases Phase 2a BANYAN Trial of Intranasal Foralumab for ALS at ALS Nexus 2026
Premium
Company Announcements
Tiziana Life Sciences Showcases Phase 2a BANYAN Trial of Intranasal Foralumab for ALS at ALS Nexus 2026
1M ago
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS Into Phase 2 Multiple Sclerosis Trial
Premium
TipRanks Newswire
Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) Receives FDA Clearance to Advance Lucid-MS Into Phase 2 Multiple Sclerosis Trial
2M ago
More DE:0RP News >

News Score - Last 7 Days

Very Positive
DE:0RP
Sector Average
Media Buzz
This Week4 articles
Weekly Average3.5 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:0RP’s Media Buzz Sentiment?
4 articles about DE:0RP were published this week. In an average week, 3.5 articles are published.
    What is DE:0RP’s weekly average amount of articles?
    In an average week, 3.5 articles about DE:0RP are published.
      What is DE:0RP’s News Sentiment?
      100% of articles about DE:0RP were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        XERSXeris Pharmaceuticals
        QTTBQ32 Bio
        ABTAbbott Laboratories
        GMABGenmab
        BAYRYBayer
        Showing the stocks with the most bullish news sentiment over the past week